Do FADS1 variants change how linoleic acid affects eicosanoid balance?

The FADS1 gene plays a central role in polyunsaturated fatty acid metabolism, specifically regulating how the body processes dietary omega-6 fatty acids.

Genetic modulation of omega-6 conversion

• Genotypic variance: The FADS1 rs174537 (G>T) single nucleotide polymorphism acts as a primary determinant of delta-5 desaturase (D5D) activity, explaining up to 18–24% of the overall variance in circulating arachidonic acid (AA).
• Enzymatic profiles: GG homozygotes exhibit the highest FADS1 expression and D5D activity, characterized by elevated circulating AA levels and high AA/DGLA product-to-precursor ratios. Conversely, TT homozygotes display significantly restricted FADS1 expression, lower D5D activity, and an accumulation of upstream precursors, while GT heterozygotes display intermediate enzymatic activity.

Mechanistic impact on eicosanoid balance

• Rate-limiting step: D5D acts as the rate-limiting enzyme that catalyzes the conversion of dihomo-gamma-linolenic acid (DGLA)—an elongation product of dietary linoleic acid (LA)—into AA, directly determining systemic and tissue AA pools.
• Eicosanoid biosynthesis: AA serves as the direct substrate for cyclooxygenase (COX) and lipoxygenase (LOX) pathways, driving the production of eicosanoids such as PGE2, LTB4, and 5-HETE.
• Dietary interaction: In individuals with highly active FADS1 variants (GG), a high dietary LA load efficiently expands AA pools, leading to a higher production of pro-inflammatory eicosanoids. In contrast, low-activity FADS1 variants (TT) limit this rate-limiting conversion, effectively decoupling dietary LA intake from downstream inflammatory eicosanoid generation and shifting the balance toward less inflammatory, DGLA-derived mediators.

Bottom line

• The FADS1 rs174537 genotype directly dictates delta-5 desaturase activity, making dietary linoleic acid load a highly influential driver of downstream pro-inflammatory eicosanoid balance in G allele carriers, while T allele carriers are biologically shielded from this conversion.